Methodology

All entries for: Bryan Therapeutics

August 22, 2026

Bryan Therapeutics

Orphan Drug Designation

Rockdale
1-50 employees

treatment of argininosuccinic aciduria

Disease Area: Rare Diseases
Source
Scroll to Top